APA (7th ed.) Citation

G, V. D. S., M, M., L, A. Á., AC, O., K, A., J, R., . . . I, S. (2023). Assessment of in vitro antimicrobial activity of clindamycin metabolites against Staphylococcus species. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 29(10), 1345. https://doi.org/10.1016/j.cmi.2023.07.005

Chicago Style (17th ed.) Citation

G, Van De Sijpe, Mylemans M, Armengol Álvarez L, Ozbey AC, Allegaert K, Rozenski J, Annaert P, Desmet S, and Spriet I. "Assessment of In vitro Antimicrobial Activity of Clindamycin Metabolites Against Staphylococcus Species." Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 29, no. 10 (2023): 1345. https://doi.org/10.1016/j.cmi.2023.07.005.

MLA (9th ed.) Citation

G, Van De Sijpe, et al. "Assessment of In vitro Antimicrobial Activity of Clindamycin Metabolites Against Staphylococcus Species." Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 29, no. 10, 2023, p. 1345, https://doi.org/10.1016/j.cmi.2023.07.005.